Dexcom G7
Powerfully Simple Glucose Monitoring.
Better Accuracy*,1,2 and Health Outcomes.2-6
Meet Dexcom G7 Continuous Glucose Monitoring (CGM)
All-in-one sensor monitors glucose levels, and sends glucose readings via Bluetooth to the wearer's display device.†
View real-time glucose data and trends, receive alerts and alarms, and other notifications to the compatible smart device† or receiver.‡
† Display devices sold separately. For a list of compatible smart devices, please visit www.dexcom.com/compatibility
Connected compatible smart device required to display readings on smartwatch
Connected compatible smart device required to display readings on smartwatch
Powerfully Simple Glucose Monitoring
Minimal training, maximum benefits, making it a valuable addition to your diabetes management. Dexcom G7 is now easier than ever to use and seamlessly integrates into your daily routine.
Zero fingerpricks§
Sends 24/7 real-time glucose numbers to your smartphone†, smartwatch|| or optional Dexcom receiver.‡
† Display devices sold separately
§ If your glucose alerts and readings from the G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
§ If your glucose alerts and readings from the G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Easy & Intuitive, all in-one-wearable
• 60% smaller than Dexcom G6
• 10-day sensor wear with an additional 12-hour grace period
• Waterproof when swimming, showering or exercising¶
• Easy sensor insertion
• Has multiple wear locations: Abdomen, back of arm and upper buttocks (children 2-6 years)
• 30-minute warm up sensor time#
• 10-day sensor wear with an additional 12-hour grace period
• Waterproof when swimming, showering or exercising¶
• Easy sensor insertion
• Has multiple wear locations: Abdomen, back of arm and upper buttocks (children 2-6 years)
• 30-minute warm up sensor time#
Clarity Integration
Allows you to access both real-time and retrospective glucose insights from the same platform.
Superior Accuracy*,1,2
Dexcom G7 is our most accurate CGM system*,1,2 giving people living with diabetes the confidence to make informed diabetes decisions.
Dexcom CGM systems have been studied in over 250 registered clinical trials**
Dexcom CGM is used for reliable diabetes treatment decisions that lead to proven results2-6
High and Low Protection
Better Health Outcomes
Real-world data has shown Dexcom CGM improves diabetes management.7,8
Dexcom G7 can help avoid lows (with Urgent Low Soon alert) and highs for pro-active adjustments.9
Dexcom G7 can help avoid lows (with Urgent Low Soon alert) and highs for pro-active adjustments.9
?qlt=default&fmt=auto&sm=aspect&aspect=16:9&w=414)
Customisable & Predictive Alerts
Dexcom G7 has a refined suite of alert settings including Urgent Low Soon Alert as well as our new quiet or vibrate modes for added discretion and personalisation. Enjoy greater peace of mind, knowing that Dexcom G7 can let you know when it’s time to take action!
Dexcom Follow app for friends & family
When Dexcom CGM users shared their glucose data with one or more followers,†† 62% of wearers reported fewer episodes of hypoglycaemia (low events).10
†Display devices sold separately
Proven Results
Lower HbA1c2-6
Increased time in range2-6
Reduce highs and lows2-6
Explore the Dexcom CGM Range
We have a range of real-time CGMs tailored to meet your needs. Explore our products to find the right one for you.
We're here to support you.
Contact us
Always read the label and use only as directed. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you. This product is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
* As compared to Dexcom G6 System.
† Display devices sold separately. To view a list of compatible smart devices, please visit www.dexcom.com/compatibility.
‡ A touch screen receiver can be acquired as an optional display device.
§ Finger pricks are required:
† Display devices sold separately. To view a list of compatible smart devices, please visit www.dexcom.com/compatibility.
‡ A touch screen receiver can be acquired as an optional display device.
§ Finger pricks are required:
- For diabetes treatment decisions when symptoms or expectations don’t match sensor readings.
- When your Dexcom G7 CGM System doesn't show both a number and trend arrow as well as during the 30-minute sensor warmup period.
- In situation of rapidly changing glucose levels.
- To confirm (impending) hypoglycemia reported by the sensor.
|| Compatible Device required for CGM data on smartwatch. For a list of compatible devices, visit dexcom.com/compatibility.
¶ Dexcom G7 sensors are waterproof and may be submerged under 2.4 metres. Dexcom receivers are not waterproof or water resistant.
# The Dexcom G7 can complete the warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
** Based on number of completed trials registered at clinicaltrials.gov as of March 2025.
†† Separate Follow app and internet connection required.
¶ Dexcom G7 sensors are waterproof and may be submerged under 2.4 metres. Dexcom receivers are not waterproof or water resistant.
# The Dexcom G7 can complete the warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
** Based on number of completed trials registered at clinicaltrials.gov as of March 2025.
†† Separate Follow app and internet connection required.
1. Dexcom G7 User Guide, 2. Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7., 3. Beck, RW, et al. Jama. 2017;317(4):371-378.
4. Beck RW, et al. Ann intern med. 2017;167(6):365-374., 5. Martens T, et al. JAMA. 2021;325(22):2262-72., 6. Laffel LM, et al. Jama. 2020;323(23):2388-239., 7. Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39., 8. Karter AJ, et al. JAMA. 2021;325(22):2273-84., 9. Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-8., 10. Polonsky WH, Diabetes Technol Ther. 2021;23(3):195-202.